Literature DB >> 32946395

HeadJoystick: Improving Flying in VR Using a Novel Leaning-Based Interface.

Abraham M Hashemian, Matin Lotfaliei, Ashu Adhikari, Ernst Kruijff, Bernhard E Riecke.   

Abstract

Flying in virtual reality (VR) using standard handheld controllers can be cumbersome and contribute to unwanted side effects such as motion sickness and disorientation. This article investigates a novel hands-free flying interface-HeadJoystick, where the user moves their head similar to a joystick handle toward the target direction to control virtual translation velocity. The user sits on a regular office swivel chair and rotates it physically to control virtual rotation using 1:1 mapping. We evaluated short-term (Study 1) and extended usage effects through repeated usage (Study 2) of the HeadJoystick versus handheld interfaces in two within-subject studies, where participants flew through a sequence of increasingly difficult tunnels in the sky. Using the HeadJoystick instead of handheld interfaces improved both user experience and performance, in terms of accuracy, precision, ease of learning, ease of use, usability, long-term use, presence, immersion, sensation of self-motion, workload, and enjoyment in both studies. These findings demonstrate the benefits of using leaning-based interfaces for VR flying and potentially similar telepresence applications such as remote flight with quadcopter drones. From a theoretical perspective, we also show how leaning-based motion cueing interacts with full physical rotation to improve user experience and performance compared to the gamepad.

Entities:  

Mesh:

Year:  2022        PMID: 32946395     DOI: 10.1109/TVCG.2020.3025084

Source DB:  PubMed          Journal:  IEEE Trans Vis Comput Graph        ISSN: 1077-2626            Impact factor:   4.579


  1 in total

1.  The systematic evaluation of an embodied control interface for virtual reality.

Authors:  Kenan Bektaş; Tyler Thrash; Mark A van Raai; Patrik Künzler; Richard Hahnloser
Journal:  PLoS One       Date:  2021-12-07       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.